Algo version: 0.98b
Jubilant Pharmova Limited is listed at the NSE Exchange
Jubilant Pharmova Limited [JUBLPHARMA.NS]
NSE Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Jubilant Pharmova Limited stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Jubilant Pharmova Limited pays dividends. Last time was Sunday 29th of September 2024 where the investors holding the stock on Friday 2nd of August 2024 were paid INR5 per share. Over the last 23 times between 2003 and 2024, Jubilant Pharmova Limited has paid INR75.45238 with an average of INR3.28 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Jubilant Pharmova Limited 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR490.05, you would have made a profit of INR461.60 per share or 94.19%

Yes, the average daily trading liquidity for Jubilant Pharmova Limited is INR559 466 thousand. You should therefore be able to get in and out of your positions relatively fast.

Jubilant Pharmova Limited has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.16, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 1.16%, which is challenging.

We have calculated the inflation risk for Jubilant Pharmova Limited to be low [0.5 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.